Abstract
The incidence of obesity, which is closely associated with the gut microbiota and chronic inflammation, has rapidly increased in the past 40 years. Therefore, the probiotic-based modification of the intestinal microbiota composition has been developed as a strategy for the treatment of obesity. In this study, we selected four Bifidobacterium adolescentis strains isolated from the feces of newborn and elderly humans to investigate whether supplementation with B. adolescentis of various origins could alleviate obesity in mice. Male C57BL/6J mice fed a high-fat diet (HFD, 60% energy as fat) received one of the following 14-week interventions: (i) B. adolescentis N4_N3, (ii) B. adolescentis Z25, (iii) B. adolescentis 17_3, (iv) B. adolescentis 2016_7_2, and (v) phosphate-buffered saline. The metabolic parameters, thermogenesis, and immunity of all treated mice were measured. Cecal and colonic microbial profiles were determined by 16S rRNA gene sequencing. Intestinal concentrations of short-chain fatty acids (SCFAs) were measured by gas chromatography-mass spectrometry (GC-MS). The B. adolescentis strains isolated from the feces of elderly humans (B. adolescentis Z25, 17_3, and 2016_7_2) decreased the body weight or weight gain of mice, whilst the strain isolated from the newborn (B. adolescentis N4_N3) increased the body weight of mice. The B. adolescentis strains isolated from the elderly also increased serum leptin concentrations and induced the expression of thermogenesis- and lipid metabolism-related genes in brown adipose tissue. All the B. adolescentis strains alleviated inflammations in the spleen and brain and modified the cecal and colonic microbiota. Particularly, all strains reversed the HFD-induced depletion of Bifidobacterium and reduced the development of beta-lactam resistance. In addition, the B. adolescentis strains isolated from the elderly increased the relative abundances of potentially beneficial genera, such as Bacteroides, Parabacteroides, and Faecalibaculum. We speculate that such increased abundance of commensal bacteria may have mediated the alleviation of obesity, as B. adolescentis supplementation decreased the intestinal production of SCFAs, thereby reducing energy delivery to the host mice. Our results revealed that certain strains of B. adolescentis can alleviate obesity and modify the gut microbiota of mice. The tested strains of B. adolescentis showed different effects on lipid metabolism and immunity regulation, with these effects related to whether they had been isolated from the feces of newborn or elderly humans. This indicates that B. adolescentis from different sources may have disparate effects on host health possibly due to the transmission of origin-specific functions to the host.
Highlights
The development of economic globalization has led to great improvements in the quality of life of many people worldwide
The consumption of an HFD causes gut microbiota disorders, accompanied by a reduction in the intestinal abundance of the genus Bifidobacterium [10], which plays important roles in intestinal health, energy metabolism, and immunity [11,12]. To reverse this HFD-induced suppression of bifidobacteria, supplementation with bifidobacteria and/or prebiotics has been explored as a treatment for animal models of obesity and it has been revealed that some strains of bifidobacteria can alleviate obesity [12,13]
We have previously shown that Bifidobacterium adolescentis alleviates metabolic disorders and non-alcoholic fatty liver disease [14,15]
Summary
The development of economic globalization has led to great improvements in the quality of life of many people worldwide. Consumption of the western diet has become increasingly commonplace throughout the world This alteration of dietary habits has increased rates of obesity and affected the gut microbiota, which has increased the prevalence of metabolic diseases [5,6]. The consumption of an HFD causes gut microbiota disorders, accompanied by a reduction in the intestinal abundance of the genus Bifidobacterium [10], which plays important roles in intestinal health, energy metabolism, and immunity [11,12] To reverse this HFD-induced suppression of bifidobacteria, supplementation with bifidobacteria and/or prebiotics has been explored as a treatment for animal models of obesity and it has been revealed that some strains of bifidobacteria can alleviate obesity [12,13]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
